Autologous cytokine‐induced killer (<scp>CIK</scp>) cells enhance the clinical response to <scp>PD‐1</scp> blocking antibodies in patients with advanced non‐small cell lung cancer: A preliminary studyYing Han, Xiubao Ren, Zhenzhen Hui et al.|Thoracic Cancer|2020Cited by 24
Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse eventsWeihong Zhang, Xiubao Ren, Yuan Meng et al.|Cancer Biology and Medicine|2021Cited by 9
Autologous Cytokine-induced Killer Cell Combination Therapy Enhances Response to Immune Checkpoint Inhibitors in Patients with Refractory Clear Cell Renal Cell CarcinomaShuzhan Li, Xiubao Ren, Jing Qin et al.|Research Square|2025Cited by 0
Camrelizumab with or without Autologous Cytokine-induced Killer Cell Therapy in Patients with Refractory Clear Cell Renal Cell Carcinoma: A Randomized Pilot StudyShuzhan Li, Xiubao Ren, Jing Qin et al.|Research Square|2025Cited by 0